Equine Health Update EHU Vol 21 Issue 02 | Page 36

EQUINE | CPD Article use in equine surgery (Hardefeldt et al. 2018). In this survey inappropriate dose, timing of administration and duration of surgical prophylaxis was common with respect to the “Protect Me” guidelines published by BEVA. Inappropriate use of enrofloxacin for surgical prophylaxis in the UK has also been reported. 2. Antibiotics in Equine Asthma Approximately 50% of vets would prescribe antibiotics to a non-pyrexic coughing adult horse in a clinical scenario questionnaire carried out in the UK (Hughes et al. 2013). Most horses with this presentation will be suffering from equine asthma (previously known as COPD, RAO, IAD) and antibiotics are not indicated. Antibiotics are commonly used in chronic lower respiratory tract disease of racehorses. Bacterial infection is unlikely in most of these cases and if there is a bacterial aetiology first-line choices are likely to be effective. There is no justification for empirical ceftiofur, cefquinome and enrofloxacin use in these cases. 3. Antibiotics in Subclinical Rhodococcus equi Pneumonia Emergence of rifampicin and macrolide resistance has been documented after widespread use of these drugs in association with ultrasonographic screening programmes. The vast majority of foals (approximately 90%) with subclinical disease with an ultrasonographic abscess score (sum of diameter of all lesions > 1cm) <10 cm recover without antibiotic treatment (Venner et al. 2013). Importantly macrolides are classified in the Watch group. The following guidelines on treatment for R.equi infection are recommended. (Giguere 2017) 36 • Equine Health Update •